11-55994562-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003697.1(OR5F1):c.64G>A(p.Glu22Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000534 in 1,610,940 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E22D) has been classified as Uncertain significance.
Frequency
Consequence
NM_003697.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5F1 | NM_003697.1 | c.64G>A | p.Glu22Lys | missense_variant | 1/1 | ENST00000278409.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5F1 | ENST00000278409.1 | c.64G>A | p.Glu22Lys | missense_variant | 1/1 | NM_003697.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151938Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000725 AC: 18AN: 248308Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134216
GnomAD4 exome AF: 0.0000528 AC: 77AN: 1459002Hom.: 1 Cov.: 34 AF XY: 0.0000744 AC XY: 54AN XY: 725572
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151938Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74202
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.64G>A (p.E22K) alteration is located in exon 1 (coding exon 1) of the OR5F1 gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glutamic acid (E) at amino acid position 22 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at